Cargando…
The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the worldwide coronavirus disease 2019 (COVID-19) pandemic. Although the pathophysiology of SARS-CoV-2 infection is still being elucidated, the nicotinic cholinergic system may play a role. To evaluate the interaction of...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051900/ https://www.ncbi.nlm.nih.gov/pubmed/36982671 http://dx.doi.org/10.3390/ijms24065597 |
_version_ | 1785015002203160576 |
---|---|
author | Carlson, Eric C. Macsai, Marian Bertrand, Sonia Bertrand, Daniel Nau, Jeffrey |
author_facet | Carlson, Eric C. Macsai, Marian Bertrand, Sonia Bertrand, Daniel Nau, Jeffrey |
author_sort | Carlson, Eric C. |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the worldwide coronavirus disease 2019 (COVID-19) pandemic. Although the pathophysiology of SARS-CoV-2 infection is still being elucidated, the nicotinic cholinergic system may play a role. To evaluate the interaction of the SARS-CoV-2 virus with human nicotinic acetylcholine receptors (nAChRs), we assessed the in vitro interaction of the spike protein of the SARS-CoV-2 virus with various subunits of nAChRs. Electrophysiology recordings were conducted at α4β2, α3β4, α3α5β4, α4α6β2, and α7 neuronal nAChRs expressed in Xenopus oocytes. In cells expressing the α4β2 or α4α6β2 nAChRs, exposure to the 1 µg/mL Spike-RBD protein caused a marked reduction of the current amplitude; effects at the α3α5β4 receptor were equivocal and effects at the α3β4 and α7 receptors were absent. Overall, the spike protein of the SARS-CoV-2 virus can interact with select nAChRs, namely the α4β2 and/or α4α6β2 subtypes, likely at an allosteric binding site. The nAChR agonist varenicline has the potential to interact with Spike-RBD and form a complex that may interfere with spike function, although this effect appears to have been lost with the omicron mutation. These results help understand nAChR’s involvement with acute and long-term sequelae associated with COVID-19, especially within the central nervous system. |
format | Online Article Text |
id | pubmed-10051900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100519002023-03-30 The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline Carlson, Eric C. Macsai, Marian Bertrand, Sonia Bertrand, Daniel Nau, Jeffrey Int J Mol Sci Article Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the worldwide coronavirus disease 2019 (COVID-19) pandemic. Although the pathophysiology of SARS-CoV-2 infection is still being elucidated, the nicotinic cholinergic system may play a role. To evaluate the interaction of the SARS-CoV-2 virus with human nicotinic acetylcholine receptors (nAChRs), we assessed the in vitro interaction of the spike protein of the SARS-CoV-2 virus with various subunits of nAChRs. Electrophysiology recordings were conducted at α4β2, α3β4, α3α5β4, α4α6β2, and α7 neuronal nAChRs expressed in Xenopus oocytes. In cells expressing the α4β2 or α4α6β2 nAChRs, exposure to the 1 µg/mL Spike-RBD protein caused a marked reduction of the current amplitude; effects at the α3α5β4 receptor were equivocal and effects at the α3β4 and α7 receptors were absent. Overall, the spike protein of the SARS-CoV-2 virus can interact with select nAChRs, namely the α4β2 and/or α4α6β2 subtypes, likely at an allosteric binding site. The nAChR agonist varenicline has the potential to interact with Spike-RBD and form a complex that may interfere with spike function, although this effect appears to have been lost with the omicron mutation. These results help understand nAChR’s involvement with acute and long-term sequelae associated with COVID-19, especially within the central nervous system. MDPI 2023-03-15 /pmc/articles/PMC10051900/ /pubmed/36982671 http://dx.doi.org/10.3390/ijms24065597 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Carlson, Eric C. Macsai, Marian Bertrand, Sonia Bertrand, Daniel Nau, Jeffrey The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline |
title | The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline |
title_full | The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline |
title_fullStr | The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline |
title_full_unstemmed | The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline |
title_short | The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline |
title_sort | sars-cov-2 virus and the cholinergic system: spike protein interaction with human nicotinic acetylcholine receptors and the nicotinic agonist varenicline |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051900/ https://www.ncbi.nlm.nih.gov/pubmed/36982671 http://dx.doi.org/10.3390/ijms24065597 |
work_keys_str_mv | AT carlsonericc thesarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline AT macsaimarian thesarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline AT bertrandsonia thesarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline AT bertranddaniel thesarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline AT naujeffrey thesarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline AT carlsonericc sarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline AT macsaimarian sarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline AT bertrandsonia sarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline AT bertranddaniel sarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline AT naujeffrey sarscov2virusandthecholinergicsystemspikeproteininteractionwithhumannicotinicacetylcholinereceptorsandthenicotinicagonistvarenicline |